Free Trial

Elevance Health (ELV) Earnings Date, Estimates & Call Transcripts

Elevance Health logo
$276.87 -25.58 (-8.46%)
Closing price 07/18/2025 03:59 PM Eastern
Extended Trading
$276.91 +0.04 (+0.01%)
As of 07/18/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Elevance Health Earnings Summary

Elevance Health released Q2 2025 earnings on July 17, 2025, reporting an EPS of $8.84, which missed analysts' consensus estimates of $9.30 by $0.46. Quarterly revenue rose 14.3% year-over-year to $49.42 billion, above the consensus estimate of $48.26 billion. With a trailing EPS of $23.50 and a P/E Ratio of 11.78, Elevance Health's earnings are expected to grow 14.99% next year, from $33.96 to $39.05 per share.

Latest Q2
Earnings Date
Jul. 17Confirmed
Consensus EPS
(Jul. 17)
$9.30
Actual EPS
(Jul. 17)
$8.84 Missed By -$0.46
Actual Revenue
(Jul. 17)
$49.42B

Q2 2025 Earnings Resources

Get Elevance Health Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Elevance Health and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ELV Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ELV Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Elevance Health Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany EPS Guidance
Q1 20252$10.40$11.57$10.9911.970 - 11.970
Q2 20253$9.36$11.43$10.26
Q3 20252$8.37$8.39$8.38
Q4 20253$4.24$7.83$5.51
FY 2025 10 $32.37 $39.22 $35.14
Q1 20262$12.18$12.79$12.49
Q2 20262$11.52$11.67$11.60
Q3 20262$9.71$9.87$9.79
Q4 20262$5.03$5.22$5.13
FY 2026 8 $38.44 $39.55 $39.00
Q1 20271$13.31$13.31$13.31

Elevance Health Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
7/17/2025Q2 2025$9.30$8.84 -$0.46$7.72$48.26B$49.42B
4/22/2025Q1 2025$10.60$11.97+$1.37$9.61$46.26B$48.77B
1/23/2025Q4 2024$3.80$3.84+$0.04$1.81$44.63B-
10/17/2024Q3 2024$9.66$8.37 -$1.29$12.38$43.47B$44.72B
7/17/2024Q2 2024$9.99$10.12+$0.13$10.39$42.99B$43.22B
4/18/2024Q1 2024$10.54$10.64+$0.10$11.69$42.49B$42.27B
1/24/2024Q4 2023$5.60$5.62+$0.02$7.61$42.19B$42.45B
10/18/2023Q3 2023$8.45$8.99+$0.54$12.53$42.69B$42.48B

Elevance Health Earnings - Frequently Asked Questions

Elevance Health (NYSE:ELV) last announced its quarterly earning data on Thursday, July 17, 2025. Learn more on ELV's earnings history.

Elevance Health updated its FY 2025 earnings guidance on Sunday, June, 22nd. The company provided earnings per share guidance of 34.150-34.850 for the period, compared to the consensus EPS estimate of 34.510. The company issued revenue guidance of -.

In the previous quarter, Elevance Health (NYSE:ELV) missed the analysts' consensus estimate of $9.30 by $0.46 with a reported earnings per share (EPS) of $8.84. Learn more on analysts' earnings estimate vs. ELV's actual earnings.

The conference call for Elevance Health's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Elevance Health's latest earnings report can be read online.
Read Transcript

Elevance Health's earnings report can be found in their filing with the SEC.
View SEC filing

Elevance Health (NYSE:ELV) has a recorded annual revenue of $177.01 billion.

Elevance Health (NYSE:ELV) has a recorded net income of $5.98 billion. ELV has generated $23.50 earnings per share over the last four quarters.

Elevance Health (NYSE:ELV) has a trailing price-to-earnings ratio of 8.39 and a forward price-to-earnings ratio of 8.15. The price/earnings-to-growth ratio is 0.81.

Elevance Health's earnings are expected to grow from $33.96 per share to $39.05 per share in the next year, which is a 14.99% increase.

More Earnings Resources from MarketBeat



This page (NYSE:ELV) was last updated on 7/20/2025 by MarketBeat.com Staff
From Our Partners